JPS58225004A - Beautifying cosmetic containing isoflavon compound - Google Patents

Beautifying cosmetic containing isoflavon compound

Info

Publication number
JPS58225004A
JPS58225004A JP10777682A JP10777682A JPS58225004A JP S58225004 A JPS58225004 A JP S58225004A JP 10777682 A JP10777682 A JP 10777682A JP 10777682 A JP10777682 A JP 10777682A JP S58225004 A JPS58225004 A JP S58225004A
Authority
JP
Japan
Prior art keywords
isoflavon
compound
compounds
soybean
genistein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10777682A
Other languages
Japanese (ja)
Other versions
JPS6019885B2 (en
Inventor
Yoshihiro Chikamatsu
義博 近松
Yutaka Ando
裕 安藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ichimaru Pharcos Co Ltd
Original Assignee
Ichimaru Pharcos Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ichimaru Pharcos Co Ltd filed Critical Ichimaru Pharcos Co Ltd
Priority to JP10777682A priority Critical patent/JPS6019885B2/en
Publication of JPS58225004A publication Critical patent/JPS58225004A/en
Publication of JPS6019885B2 publication Critical patent/JPS6019885B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Abstract

PURPOSE:A beautifying cosmetic having a little change in browing phenomena with time after pharmaceutical manufacturing, containing an isoflavon compound such as daidzein, daidzin, genistin, etc. obtained from an extracted material of soybeans, arrowroot, etc. CONSTITUTION:A beautifying cosmetic containing one or more isoflavon compounds selected from daidzein, diadzin, genistein, and genistin, having fundamental skeleton shown by the formula obtained from an extracted material of soybean, arrowroot (Pueraria). The compounds have strong inhibitory action on the formation of melanin, are easily manufactured into pharmaceutical preparation, have a little change in browing phenomena with time, and advantageously made into preparation. The content of isoflavon compound is about 0.005- 0.1wt%. A crude extract containing isoflavon can be used without isolating the compound, and, in this case, the total amount of the isoflavon compound in the preparation is preferably >=0.02wt%.

Description

【発明の詳細な説明】 本発明は、イソフラボン化合物の内、ダイズゼイン(D
a i dze 1n ’ 015HIO04) 、ゲ
ニスタイン(G enis te in : (! 1
5H1005)、ダイズヂン(Daid−21n;C2
1H2oO9)、ゲニスチン(Gen1stin:02
1H200工。)、から選びたした一種以上を用いてな
る、新規な美白化粧料に関する。本発明者らは、天然動
・植物由来の抽出物の有効利用について研究を続け、各
種植物色素の中から、大豆やクズ根中に含まれる色素成
分を含有する抽出物には、チロシナーゼ活性を阻害して
、これによりメラニン色素の生成を抑制させる物質のあ
ることを発見した。そこで、この物質についてさらに追
試を行い、その結果、植物の根茎又は種子中に天然に含
まれる特定のインフラボン化合物にはメラニン生成抑制
作用があり、なかでも大豆やクズ根中に含まれるところ
のダイズゼインや、ゲニスタイン、それの配糖体である
ダイズヂンやゲニスチンには、強いメラニン生成抑制作
用があることがわかったので、これをもとに、本発明者
らは、美白効果を期待する化粧料への利用を考え、本発
明を完成するに至った。
Detailed Description of the Invention The present invention provides soybean zein (D
a i dze 1n' 015HIO04), Genis te in: (! 1
5H1005), Daizujin (Daid-21n; C2
1H2oO9), Gen1stin:02
1H200 construction. ), a novel whitening cosmetic comprising one or more selected from the following. The present inventors have continued research on the effective use of extracts derived from natural animals and plants, and among various plant pigments, extracts containing pigment components contained in soybeans and kudzu roots have tyrosinase activity. We have discovered that there is a substance that inhibits the production of melanin pigment. Therefore, we conducted further tests on this substance, and found that certain inflavone compounds naturally contained in plant rhizomes or seeds have an inhibitory effect on melanin production, and in particular, those found in soybean and kudzu roots have an inhibitory effect on melanin production. It has been found that soybean zein, genistein, and its glycosides, soybean zein and genistein, have a strong melanin production inhibiting effect.Based on this, the present inventors developed a cosmetic product that is expected to have a whitening effect. The present invention has been completed by considering the use for this purpose.

上述したイソフラボン化合物は、製剤化も容易であり、
外用塗布の形態で、化粧料中に添加して用いるこ゛とに
よって、肌に対する美白効果が期待されるが、実際の処
方化に当っては、特に単離された物質を配合しなくても
、後述する様なインフラボン化合物を主体に抽出したエ
キスの状態で用いることも出来る。
The above-mentioned isoflavone compounds are easy to formulate,
It is expected to have a whitening effect on the skin when added to cosmetics in the form of external application, but in actual formulation, even if isolated substances are not included, the following will be applied. It can also be used in the form of an extract containing mainly infravon compounds.

美白効果を期待して用いられる公知物質としては、その
代表的なものにはアスコルビン酸ヤ、グルタチオンなど
があり、さらには、本発明者らがアロエから単離したア
ントラキノン系化合物であるアロインなどがある。アロ
インについては、すでに特許公報「昭53−45376
号」で示されているごとくであり、アスコルビン酸やグ
ルタチオンの様な、製剤化後における不安定性がなく、
長期間にわたりチロシナ、−ゼ活性を阻害して、メラニ
ン生成抑制作用を有するものとして、広く利用されてき
たが、本発明者らは、さらに検索を続けた結果、本発明
を完成するに至った。本発明に用いる、インフラボン化
合物の特徴は、アロインなどが示すような、製剤化後の
経時的な褐変化現象が少なく、処方化においても有利な
ものである。以下に、本発明による実験等の成績をもと
に、より具体的に述べる。
Representative known substances used with the expectation of whitening effects include ascorbic acid and glutathione, as well as aloin, an anthraquinone compound that the present inventors isolated from aloe vera. be. Aloin has already been published in the patent publication ``Sho 53-45376.
Unlike ascorbic acid and glutathione, it is not unstable after formulation.
Although it has been widely used as a substance that inhibits tyrosina,-ase activity for a long period of time and has a suppressive effect on melanin production, the present inventors continued their search and as a result, completed the present invention. . The inflavone compound used in the present invention is characterized by less browning phenomenon over time after formulation, as shown by aloin, and is advantageous in formulation. The present invention will be described in more detail below based on the results of experiments and the like.

〔メラニン色素性成抑制作用〕[Melanin pigment growth inhibitory effect]

L−チロシンに、チロシナーゼを作用させて、これによ
って生ずる黒色メラニンの生成量を、分光々度肝により
、640nm  の波長で吸光度を測定して求める方法
を採用した。
A method was adopted in which tyrosinase was allowed to act on L-tyrosine, and the amount of black melanin produced was determined by measuring the absorbance at a wavelength of 640 nm using a spectrophotometer.

反応系の組成は、L−チロシン(1,0m9 / tn
t)0.5m7.15分の1Mリン酸緩衝液(1)H6
゜8)2.Qmj、硫酸銅(1%溶液)0.05trL
t、チロシナーゼ(1m9/d : p N=0.47
32)  1゜04に、精製水又は阻害剤液2.0Sに
より実施した。尚、測定は37.5℃の恒温槽中で、3
0分間インキュヘ−トの後に、吸光度を求め、ブランク
(阻害剤無添加)との吸光度との比較によって、各検体
の阻害率を求めたものである。
The composition of the reaction system was L-tyrosine (1,0 m9/tn
t) 0.5m 7.15 minutes of 1M phosphate buffer (1) H6
゜8)2. Qmj, copper sulfate (1% solution) 0.05trL
t, tyrosinase (1 m9/d: p N=0.47
32) Conducted at 1°04 with purified water or inhibitor solution 2.0S. The measurement was carried out in a constant temperature bath at 37.5°C.
After incubation for 0 minutes, the absorbance was determined, and the inhibition rate of each sample was determined by comparing the absorbance with that of a blank (no inhibitor added).

その結果は、第1表に示すごとく、既知物質ビタミンO
と等濃度で用いて、はぼ同等の数値を示すことがわかっ
た。
The results, as shown in Table 1, are known substance vitamin O.
It was found that when used at the same concentration as , it showed the same numerical value as .

次に、第1表に示すインフラボン化合物における、添加
量や皮膚に対する安全性及び安定性などについてみると
、実際的な処方化における添加量は、いずれもo、o 
o 5〜0.1%程度を、。
Next, when looking at the amount added and the safety and stability for the skin of the inflavone compounds shown in Table 1, the amount added in practical formulations is o, o
o About 5-0.1%.

他の軟膏又は化粧料ベース中に配合して用いると良い。It may be used by incorporating it into other ointments or cosmetic bases.

治療分野においては、1%程度の高含有した処方化も可
能であるが、水に対する溶解性は低いので、処方中には
適当な分散剤を用いて均一な分散を行うことが望ましい
。又、第1表に示すイソフラボン化合物は、併用して用
いてもよく、その場合は、処方中のインフラボン化合物
としての濃度が0.005〜0.1%の範囲で十分なチ
ロシナーゼ活性抑制作用を示す。
In the therapeutic field, it is possible to formulate a formulation with a high content of about 1%, but since the solubility in water is low, it is desirable to use an appropriate dispersant in the formulation to ensure uniform dispersion. In addition, the isoflavone compounds shown in Table 1 may be used in combination, and in that case, a sufficient tyrosinase activity inhibitory effect can be obtained when the concentration of the inflavone compound in the formulation is in the range of 0.005 to 0.1%. shows.

さらに、わざわざ植物中から単離することは、コスト的
にも高くなるので、インフラボンを主体とするエキス、
すなわちインフラボン含有粗エキスの状態で使用するこ
とも可能である。
Furthermore, it is costly to isolate from plants, so extracts mainly containing infravon,
That is, it is also possible to use it in the form of an infravon-containing crude extract.

エキスを用いる際は、処方中のイソフラボン化合物の総
量(濃度)が、0.02%以上含まれていることが望ま
しい。
When using an extract, it is desirable that the total amount (concentration) of isoflavone compounds in the formulation is 0.02% or more.

皮膚に対する一次刺激性は、あらがしめ5%のエタノー
ル含有水溶液に、それぞれ、第1表に示したイソフラボ
ン化合物を1%添加した液を用い、20名の女性を対象
に貼布試験により、24時間後の異状について観察した
が、いずれの化合物も、実際の処方に必要な配合量にお
いては、何ら問題はなく、安全性が高いものと評価され
た。
Primary irritation to the skin was determined by a patch test on 20 women using a 5% ethanol-containing aqueous solution with 1% of each of the isoflavone compounds shown in Table 1 added. Although abnormalities were observed after a period of time, there were no problems with any of the compounds in the amounts required for actual formulations, and they were evaluated to be highly safe.

次に、本発明に用いるインフラボン化合物は、その原料
゛として、大豆やクズ根(日周:カッコン)などを用い
、これから抽出したものが良い。つまり、大豆やクズ根
は、入手しやすく、さらにコスト的にも生産原価の低減
に貢献する。このことは、たとえば大豆では、大豆油や
大豆蛋白を抽出する工程で分離することも出来るし、一
方のクズ根は漢方処方剤として用いられる他に、クズデ
ン粉を抽出する際に、分離することが出来るなどのメリ
ットがあり、スタート物質の有効利用が促進できること
である。
Next, the inflavone compound used in the present invention is preferably extracted from soybean, kudzu root (diurnal period: kakkon), etc., as its raw material. In other words, soybeans and kudzu roots are easy to obtain and also contribute to lower production costs. For example, soybeans can be separated in the process of extracting soybean oil and soy protein, while kudzu root is used as a Chinese herbal medicine, and it can also be separated when extracting kudzu starch powder. This has the advantage that it is possible to use the starting material effectively.

インフラボン化合物の基本骨格は、次に示すごとくであ
るが、これらの植物中の所在番こつし)でみると、その
代表的なものは、第2〜3表中こ示すごとくのものが知
られている。この4也、マメ科、アヤメ科、バラ科、ク
ワ科などの植物中にも確認されているが、第2〜3表中
で示すごとくの化合物は、強弱の差はあっても、し)ず
れもその構造上からして、ダイズヂンなどの第1表に示
す様な、メラニン色素の生成を抑制する作用を有してい
ることが、後表(第4表)力)らみて、示唆された。
The basic skeletons of inflavone compounds are as shown below, but looking at their location in plants, the representative ones are those shown in Tables 2 and 3. It is being These four compounds have also been confirmed in plants of the Fabaceae, Iridaceae, Rosaceae, Moraceae, etc., but the compounds shown in Tables 2 and 3, although they differ in strength, are Judging from its structure, it is suggested that it has the effect of suppressing the production of melanin pigments as shown in Table 1, such as soybean ginseng (Table 4). Ta.

(イソフラボンの基本骨格) 〔第2表〕 (インフラボン化合物と植物基原)〔第3
表〕 (インフラボン配糖体と植物基原)次に、インフ
ラボン化合物を主体に抽出したエキスには、通常は前記
第3表に示すごとくの、インフラボン配糖体と共存した
状態で得られる0 抽出′法は、基本的には公知なインフラボン化合物の粗
製法や精製化法などに準拠して行なえばよいが、本発明
者は、次のような方法により、公知な抽出法に改良を加
え、イソフラボン化合物を得た。もちろん、市販には、
すでにそれぞれ嘔−な化合物があり、いずれを処方中に
配合して用いても、メラニン色素生成抑制効果をもった
化粧料が得られる。
(Basic skeleton of isoflavones) [Table 2] (Inflavone compounds and plant bases) [Table 3]
Table] (Inflavone glycosides and plant sources) Next, extracts mainly containing infravon compounds are usually obtained in a state in which they coexist with inflavone glycosides, as shown in Table 3 above. Basically, the extraction method may be carried out in accordance with known methods for crude production and purification of infravon compounds, but the present inventor has developed a method for the extraction of infravon compounds using the following method. After making improvements, an isoflavone compound was obtained. Of course, commercially available
Already, there are compounds that have negative effects on each of them, and no matter which one is used in a formulation, a cosmetic product that has the effect of suppressing melanin pigment production can be obtained.

〔抽出法〕[Extraction method]

(1)大豆からのインフラボン類の抽出新鮮な大豆1 
kgを粉砕機を用いて微粉となし、石油エーテル21に
浸漬し、還流下にb0湿して、含有される脂質及び植物
ステロール等の脂溶性分画を抽出した後、濾過して残渣
を取り、再びメタノール21にて還流下に加温抽出操作
を繰返す。抽出終了後、濾過して濾液を採取し、減圧下
に濃縮した後、(AcO)、Pb (酢酸鉛)の飽和水
溶液を加えて、淡黄色の沈澱物を除き、濾液に塩基性酢
酸鉛の飽和水溶液を加え、黄色沈澱物を濾取して、メタ
ノール中に懸濁させ、硫化水素等を用いて、完全に脱鉛
した後、濾液を蒸発乾固すると、淡黄色状の粉末が得ら
れる。このものには、主としてダイズゼイン、ダイズヂ
ン、ゲニスタイン、ゲニスチンと共に、他に2〜6種程
度の、インフラボン化合物を含有したエキスとして得る
ことが出来る。
(1) Extraction of infravones from soybeans Fresh soybeans 1
kg into a fine powder using a grinder, immersed in petroleum ether 21, moistened with b0 under reflux to extract fat-soluble fractions such as lipids and plant sterols, and filtered to remove the residue. Then, the heating extraction operation is repeated again with methanol 21 under reflux. After the extraction, the filtrate was collected by filtration, concentrated under reduced pressure, and a saturated aqueous solution of (AcO) and Pb (lead acetate) was added to remove the pale yellow precipitate. Add a saturated aqueous solution, filter the yellow precipitate, suspend it in methanol, completely delead using hydrogen sulfide, etc., and then evaporate the filtrate to dryness to obtain a pale yellow powder. . This product can be obtained as an extract containing mainly soybean zein, soybean gin, genistein, and genistin, as well as about 2 to 6 other inflavone compounds.

(2)イソフラボン化合物の単離 上記(1)で得たイソフラボン化合物を含有する粉末を
、水飽和ブタノールに溶解し、アルミナを吸着剤とし、
水飽和ブタ/−ルを展開剤トシて、カラムクロマトグラ
フィーを行い、紫外線下で観察すると、紫青色の蛍光帯
が確認できるので、その各々の蛍光帯を分取して得る。
(2) Isolation of isoflavone compounds The powder containing the isoflavone compounds obtained in (1) above is dissolved in water-saturated butanol, and alumina is used as an adsorbent.
Column chromatography is performed using water-saturated butyl as a developing agent, and when observed under ultraviolet light, purple-blue fluorescent bands can be confirmed, and each fluorescent band is fractionated and obtained.

さらに、常法により加水分解を行えば、これによってダ
イズゼイン、ゲニスタインなどが得られる。単離法に関
する文献としては、たとえば「薬学雑誌 79.  P
、? 57(195a)染出、村」−」が有る。
Furthermore, if hydrolysis is carried out by a conventional method, soybean zein, genistein, etc. can be obtained. Literature on isolation methods includes, for example, “Pharmaceutical Journal 79. P.
,? 57 (195a) Somede, Mura"-" is there.

(3)クズ根からのインフラボン類の抽出葛根l kg
をメタノールで数回熱時抽出し、抽出液を合して、減圧
下に濃縮し、濃縮液に酢酸鉛の飽和水溶液を加え、黄色
沈澱物を濾取し、メタノールの適量に懸濁し、硫化水素
等を用いて、脱鉛を行い、減圧下に濾液を蒸発乾固して
、淡黄色の粉末を得る。このものには、ダイズゼイン、
ダイズヂン及びゲニスタイン、ゲニスチン等のイソフラ
ボン化合物が主体に含まれている。
(3) Extraction of infravones from kudzu root 1 kg
was hot-extracted several times with methanol, the extracts were combined and concentrated under reduced pressure, a saturated aqueous solution of lead acetate was added to the concentrate, the yellow precipitate was collected by filtration, suspended in an appropriate amount of methanol, and sulfurized. Delead is carried out using hydrogen or the like, and the filtrate is evaporated to dryness under reduced pressure to obtain a pale yellow powder. This stuff includes soybean zein,
It mainly contains isoflavone compounds such as soybean gin, genistein, and genistein.

(4)ダイズゼインの単離 上記(3)で得たクズ根からのインフラボ・ン化合物の
複合状態にある抽出物は、前記(2)で示した、カラム
クロマトグラフィーによる方法によって、紫外線下で観
察すると、9個の紫青色の蛍光帯が確認できる。ダイズ
ゼインヲ得るには、カラム下部から3番目の蛍光帯を分
取し、常法に従って加水分解し、ダイズゼインを上記の
抽出法(1)又は(3)によって得られた、イソフラボ
ン化合物の複合状態で含有する粉末の、チロシナーゼ活
性阻害による、メラニン色素の生成抑制作用は、抽出槌
原による影響は少なく、大豆でもクズ根から抽出したも
のでも、強力に抑制作用を示し、0.]%含有水溶液で
は、70〜80%の抑制作用を有している。第4表は、
インフラボン化合物の複合状態で得られた粉末(エキス
)が示す、メラニン色素生成抑制作用である。
(4) Isolation of soybean zein The extract in a complex state of inflavone compounds from kudzu roots obtained in (3) above was observed under ultraviolet light using the column chromatography method shown in (2) above. Then, nine purple-blue fluorescent bands can be seen. To obtain soybean zein, the third fluorescent band from the bottom of the column is fractionated and hydrolyzed according to a conventional method, containing soybean zein in a complex state of isoflavone compounds obtained by the above extraction method (1) or (3). The inhibitory effect of the melanin pigment production by the tyrosinase activity inhibition of the powder is little affected by the extract Tsuchihara, and both the extracts from soybeans and kudzu roots show a strong inhibitory effect. ]% containing aqueous solution has an inhibitory effect of 70 to 80%. Table 4 is:
This is the melanin pigment production inhibiting effect exhibited by the powder (extract) obtained in a composite state of inflavone compounds.

インフラボン化合物を複合状態で含む抽出粉末(エキス
)として得たものは、微黄色の結晶状の粉末を呈してい
るが、この色調は、インフラボンの基本骨格に、糖が結
合したところの配糖体である。ダイズゼインやゲニスタ
インでは、糖の結合はなく、この単離されたものでは、
白色又は淡黄色の結晶状の粉末を呈している。
The extracted powder (extract) containing infravon compounds in a complex state appears as a slightly yellow crystalline powder, but this color is due to the structure of sugars bonded to the basic skeleton of infravones. It is a glycoside. In soybean zein and genistein, there is no sugar bond, and in this isolated product,
It appears as a white or pale yellow crystalline powder.

〔安定性〕〔Stability〕

インフラボン化合物を処方化し、その製剤上の安定性を
みると、経時的な色調の変化や、メラニン色素の抑制作
用が経時的に低下するような傾向は少ないが、欠点とし
ては水に対する溶解性が低いので、化粧料中での配合に
おいて、0.5%以上のインフラボン化合物を添加する
ような場合では、均一な分散状態で用いることが望It
 t、い。
When inflavone compounds are formulated and their stability is examined, there is little tendency for the color tone to change over time or for the inhibitory effect on melanin pigments to decrease over time, but the disadvantage is that the solubility in water is Therefore, when adding 0.5% or more of inflavone compounds to cosmetics, it is desirable to use them in a uniformly dispersed state.
T, yes.

また、水に対する溶解性は、抽出法(1)や(3)で示
したところのインフラボン化合物の複合状態の粉末の方
が高くなる。この原因としては、イソフラボンの配糖体
の方が、水に対する溶解性が良いが、それのみではなく
て、イソフラボン配糖体の共存下においては、水に対し
て他の化合物、たとえばダイズゼインやゲニスタインの
溶解性も向上することである。
Further, the solubility in water is higher for the powder in a composite state of the infravon compound shown in extraction methods (1) and (3). The reason for this is that isoflavone glycosides have better solubility in water, but this is not the only reason; in the coexistence of isoflavone glycosides, other compounds, such as soybean zein and genistein, It also improves the solubility of.

したがって、むしろ、各種のイソフラボン化合物が複合
状態に含まれているエキスを用イルことの方が、単離さ
れたダイズゼインやゲニスタインを用いるより地1利で
あるとも考えられた。次に、化粧料への処方例を示す。
Therefore, it was thought that it would be more advantageous to use an extract containing various isoflavone compounds in a complex state than to use isolated soybean zein or genistein. Next, examples of formulations for cosmetics will be shown.

〔処方例〕[Prescription example]

(1) 化粧水 エタノール・・・・・−・・拳・・・・e11Φ・・・
 9.0  %乳酸・・・・・・・・・・・・・・・・
・・・・・・・・・ 0.2クエン酸*s***会・俸
・・−■・・・・110・ 0.9ゲニスチン・・・・
・・―・・・・・φ・・す・・、  0.02ゲニスタ
イン−拳−・e・@畢・・・・1111・・・ 010
3メチルパラベンll1111・・・mamms@・・
・ 0.1香料・・・・・・・・・・・・・・・・・・
・・・・・・・ 0.1精製、水・・・・・・・・・・
・・・・・・・・・・・・・全i1.100(2)  
ローション 鯨ロウ・・・・・・・・・・・・・・・・・・・φ・・
  2.0  %ミツロウ・・・・・・・・・・・・1
111・・・Q・・ 16.0流動パラフイン・・・・
・・・・・・φ・・・ 46.5抽出法1又3で得た粉
末(エキス)・・・、0.5セチルアルコール−・嘩・
・・e@−・・φ  2.0精製水・・・・・・・・・
・・・・・・・・・・・・・ 31.3ホウ砂***s
*ame*sa***e*1+eas*a   1+0
香料・・・・・・・・・・・・・・・・・・・・・・・
・  0.5メチルパラベンa@@@*@@@@@*@
@@   0,2(3) バニンングクリーム ステアリン酸 ソルビタン・モノステアレート・・16.0 %ポリオ
キシエチレンソルビタン・02.0モノステアレート プロピレングリコール・・・・・・・・・ 1.5ゲニ
スタイン又はゲニスチン・・、0.8〜1.0精製水・
・・・・・・・・・・・・・・・・・・・・・・65.
3メチルパラベン−・・・・・・・・・・・9・・ 0
.2(4)  コールドクリーム ミツロウ・・・・・・・・・e・・・・・・・・・・ 
10.0 %セレシン・・・・・・・・・・・me・−
・・・・*10.0ワセリン・・・・・・・・・e@・
・拳・轡・・・・ 15+Oラノリン拳・・・・・・・
・・・・・・@O・・・・  5.0流動ハラフイン・
・011・・・・・・・・・ 17.0米胚芽油(オリ
ザオイル5−1)・・・・ l O,0ソルビタンモノ
オレエートφ・、、   4.0抽出法1又は3で得た
粉末(エキス)又は、ゲニスタインとゲニスーチンが1
対1の割合で混合させた粉末・1・・・・・・・・・ 
 1.0精製水・・・・・・・・・・・・・・・・・・
・・・・ 26.7香料・・・・・・・・・・・・・・
・・・・・・・・・・  1.0メチルパラベンama
mam*ammsa*m   0.3(5)  ファン
デーションクリーム 流動パラフィン111111111111111111
1111@1111 2 ?+O%ラ / リ ン ・
・・・・・・・・・働・11e・・・・、、10.0固
型パラフィン***’aa*ammam*ma   5
,0ソルビタンセスキオレエート@11111111 
 5+0粉未着色料・・・・・・・・・・・・・・・・
・・ 32.7シルクゲンG (絹プロティンパウダー
)e・   2.0抽出法1又は3で得た粉末(エキス
)又は夕。
(1) Lotion ethanol...---Fist...e11Φ...
9.0% lactic acid・・・・・・・・・・・・・・・
・・・・・・・・・ 0.2 Citric acid *s*** Society・Pay・・−■・・・・110・ 0.9 Genistin・・・・
・・・・・・・・・・φ・・su・・0.02 Genistein-Fist・・e・@畢・・1111・・010
3 Methylparabenll1111...mamms@...
・0.1 Fragrance・・・・・・・・・・・・・・・・
・・・・・・・・・ 0.1 Purification, water・・・・・・・・・
・・・・・・・・・・・・All i1.100 (2)
Lotion whale wax・・・・・・・・・・・・・・・φ・・
2.0% Beeswax・・・・・・・・・1
111...Q... 16.0 Liquid paraffin...
・・・・・・φ・・・ 46.5 Powder (extract) obtained by extraction method 1 or 3..., 0.5 cetyl alcohol・・
・・e@−・・φ 2.0 Purified water・・・・・・・・・
・・・・・・・・・・・・・・・ 31.3 Borax***s
*ame*sa***e*1+eas*a 1+0
Fragrance・・・・・・・・・・・・・・・・・・・・・
・0.5 Methylparaben a@@@*@@@@@*@
@@ 0,2(3) Banning Cream Sorbitan Stearate/Monostearate...16.0% Polyoxyethylene Sorbitan/02.0 Monostearate Propylene Glycol...1.5 Genistein or genistein..., 0.8-1.0 purified water.
・・・・・・・・・・・・・・・・・・・・・65.
3 Methyl paraben - 9... 0
.. 2 (4) Cold cream beeswax・・・・・・・・・e・・・・・・・・・・
10.0% ceresin・・・・・・・・・・me・−
・・・・*10.0 Vaseline・・・・・・・・・e@・
・Fist・轡・・・・15+O Lanolin fist・・・・・・・
・・・・・・@O・・・ 5.0 Liquid Halafine・
・011・・・・・・・・・ 17.0 Rice germ oil (Oryza oil 5-1)・・・・ l O,0 Sorbitan monooleate φ・, 4.0 Obtained by extraction method 1 or 3 powder (extract) or genistein and genisutin
Powder mixed at a ratio of 1:1...
1.0 Purified water・・・・・・・・・・・・・・・・・・
・・・・・・ 26.7 Fragrance・・・・・・・・・・・・・
・・・・・・・・・・・・ 1.0 Methylparaben ama
mam*ammsa*m 0.3 (5) Foundation cream liquid paraffin 111111111111111111
1111@1111 2? +O% La / Lin ・
・・・・・・・・・Work・11e・・・・、10.0 Solid paraffin ***'aa*ammam*ma 5
,0 sorbitan sesquioleate @11111111
5+0 powder no coloring agent・・・・・・・・・・・・・・・・
... 32.7 Silkgen G (silk protein powder) e. 2.0 Powder (extract) or protein obtained by extraction method 1 or 3.

イズゼイン、ダイズヂン、ゲニスチン、ゲニスタインの
いずれか1種類・・・・・0.2〜1.0精製水−・・
・・・・・・・−・・・・・・φ・・φ・・16〜18
.0香料・・・・・・・・・・・・・・・・・・・・・
・・・・ 0.1パラベン類の混合・−・II″ama
sses  Q・3
One type of iszein, daizudin, genistin, genistein...0.2~1.0 purified water...
・・・・・・・・・−・・・・・・φ・・φ・・16〜18
.. 0 Fragrance・・・・・・・・・・・・・・・・・・
...0.1 Mixture of parabens ---II"ama
sses Q・3

【図面の簡単な説明】[Brief explanation of drawings]

図面の添附なし。 特許出願人 No drawings attached. patent applicant

Claims (1)

【特許請求の範囲】[Claims] インフラボン化合物から選択したダイズゼイン、ダイズ
チン、ゲニスタイン、ゲニスチンから、その一種以上を
含有させてなることを特徴とする美白化粧料。
A whitening cosmetic containing one or more of soybean zein, soybean tin, genistein, and genistin selected from inflavone compounds.
JP10777682A 1982-06-23 1982-06-23 Whitening cosmetics containing isoflavone compounds Expired JPS6019885B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10777682A JPS6019885B2 (en) 1982-06-23 1982-06-23 Whitening cosmetics containing isoflavone compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10777682A JPS6019885B2 (en) 1982-06-23 1982-06-23 Whitening cosmetics containing isoflavone compounds

Publications (2)

Publication Number Publication Date
JPS58225004A true JPS58225004A (en) 1983-12-27
JPS6019885B2 JPS6019885B2 (en) 1985-05-18

Family

ID=14467723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10777682A Expired JPS6019885B2 (en) 1982-06-23 1982-06-23 Whitening cosmetics containing isoflavone compounds

Country Status (1)

Country Link
JP (1) JPS6019885B2 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039832A1 (en) * 1995-06-07 1996-12-19 Kung Patrick C Compounds and methods for promoting hair growth
EP0829261A3 (en) * 1996-09-13 1998-04-01 Director General of Shikoku National Agricultural Experiment Station, Ministry of Agriculture, Forestry and Fisheries Composition comprising isoflavone or derivatives thereof for promoting fat-degradation in fat-cells
FR2769502A1 (en) * 1997-10-14 1999-04-16 Sederma Sa Cosmetic and dermopharmaceutical compositions containing a trefoil extract to counteract the dermal effects of the menopause
JPH11269066A (en) * 1998-03-20 1999-10-05 Kao Corp Skin-bleaching agent for peroral administration and skin-bleaching food
US6093411A (en) * 1998-03-16 2000-07-25 The Procter & Gamble Company Compositions for regulating skin appearance
EP1205179A1 (en) * 2000-11-10 2002-05-15 L'oreal Cosmetic composition comprising an aminophenol derivative and an isoflavonoid
EP1234572A1 (en) * 2001-02-26 2002-08-28 Mibelle AG Cosmetics Skin treatment compositions containing isoflavone aglycones
JP2002265343A (en) * 2001-03-07 2002-09-18 Ichimaru Pharcos Co Ltd Cosmetic composition
EP1074240A3 (en) * 1999-07-27 2003-01-29 JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
EP1041964A4 (en) * 1998-09-10 2003-09-03 Avon Prod Inc Method and compositions for reducing dermatological aging and for reducing bruising
KR100849678B1 (en) * 2006-06-28 2008-08-01 주식회사 정식품 Extracts of soy hypocotyl with effects on skin whitening and composition comprising the same
US7897144B2 (en) 2001-02-28 2011-03-01 Johnson & Johnson Comsumer Companies, Inc. Compositions containing legume products
JP2011213600A (en) * 2010-03-31 2011-10-27 Toyo Shinyaku Co Ltd Bleaching agent
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
JP2015003869A (en) * 2013-06-19 2015-01-08 株式会社ブルーム・クラシック Skin-whitening agent, and skin cosmetics for whitening

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6357886U (en) * 1986-10-03 1988-04-18
JP2002097149A (en) * 2000-09-20 2002-04-02 Noevir Co Ltd Skin care preparation
JP2012193200A (en) * 2001-10-31 2012-10-11 Daicho Kikaku:Kk Dermatologic preparation
KR101483440B1 (en) * 2008-05-02 2015-01-19 (주)아모레퍼시픽 Medicinal plants extract using processing of herbal medicine and composition of skin external application comprising the same

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039832A1 (en) * 1995-06-07 1996-12-19 Kung Patrick C Compounds and methods for promoting hair growth
EP0829261A3 (en) * 1996-09-13 1998-04-01 Director General of Shikoku National Agricultural Experiment Station, Ministry of Agriculture, Forestry and Fisheries Composition comprising isoflavone or derivatives thereof for promoting fat-degradation in fat-cells
FR2769502A1 (en) * 1997-10-14 1999-04-16 Sederma Sa Cosmetic and dermopharmaceutical compositions containing a trefoil extract to counteract the dermal effects of the menopause
WO1999018927A1 (en) * 1997-10-14 1999-04-22 Sederma S.A. Compositions for cosmetic and dermopharmaceutical use containing a plant extract obtained from clover (trifolium sp.)
US6093411A (en) * 1998-03-16 2000-07-25 The Procter & Gamble Company Compositions for regulating skin appearance
JPH11269066A (en) * 1998-03-20 1999-10-05 Kao Corp Skin-bleaching agent for peroral administration and skin-bleaching food
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
EP1041964A4 (en) * 1998-09-10 2003-09-03 Avon Prod Inc Method and compositions for reducing dermatological aging and for reducing bruising
EP1074240A3 (en) * 1999-07-27 2003-01-29 JOHNSON & JOHNSON CONSUMER PRODUCTS, INC. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
FR2816502A1 (en) * 2000-11-10 2002-05-17 Oreal COSMETIC COMPOSITION CONSISTING OF AN AMINOPHENOL DERIVATIVE AND AN ISOFLAVONOIDE
EP1205179A1 (en) * 2000-11-10 2002-05-15 L'oreal Cosmetic composition comprising an aminophenol derivative and an isoflavonoid
EP1234572A1 (en) * 2001-02-26 2002-08-28 Mibelle AG Cosmetics Skin treatment compositions containing isoflavone aglycones
US7897144B2 (en) 2001-02-28 2011-03-01 Johnson & Johnson Comsumer Companies, Inc. Compositions containing legume products
JP2002265343A (en) * 2001-03-07 2002-09-18 Ichimaru Pharcos Co Ltd Cosmetic composition
KR100849678B1 (en) * 2006-06-28 2008-08-01 주식회사 정식품 Extracts of soy hypocotyl with effects on skin whitening and composition comprising the same
JP2011213600A (en) * 2010-03-31 2011-10-27 Toyo Shinyaku Co Ltd Bleaching agent
JP2015003869A (en) * 2013-06-19 2015-01-08 株式会社ブルーム・クラシック Skin-whitening agent, and skin cosmetics for whitening

Also Published As

Publication number Publication date
JPS6019885B2 (en) 1985-05-18

Similar Documents

Publication Publication Date Title
JPS58225004A (en) Beautifying cosmetic containing isoflavon compound
Benzidia et al. Chemical composition and antioxidant activity of tannins extract from green rind of Aloe vera (L.) Burm. F.
KR100311439B1 (en) Hair growth stimulant
JP3816262B2 (en) Ceramide production promoter
US20010031735A1 (en) Flavonoide esters and their use notably in cosmetics
AU2012208626B2 (en) Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents
JPH04342519A (en) Skin cosmetic
JP2002003363A (en) Cosmetic composition
KR100667448B1 (en) Cosmetic composition containing a gynostemma pentaphyllum makino extract
US6071525A (en) Whitening cosmetics containing mulberrin
AU2012208626A1 (en) Monoterpene derivatives of chalcone or dihydrochalcone and their use as depigmenting agents
KR100460133B1 (en) Production Method of Catechin with High Antioxidative Activity from The Extracts of Rosa davurica Pall
JPS63316711A (en) Beautifying and whitening cosmetic
JP3661981B2 (en) Antiperspirant
JP2002370922A (en) Cosmetic containing japanese plum extract
JPH0899891A (en) Skin external agent
KR100530669B1 (en) Cosmetic Compositions Comprising Lactate and Glycyrrhiza Uralensis Extracts for Skin Whitening
JPH11349436A (en) Collagenase inhibitor and skin agent containing the same and used for external use
KR101837422B1 (en) Cosmetic composition containing ginsenoside F1, and broussonetia kazinoki extract or oldenlandia diffusa extract
KR950006064B1 (en) Method of stabilization of diospyros kaki l. flavonoids
Ukekpe et al. Phytochemical Screening and Antioxidant properties of Stem bark of Khaya senegalensis (Dry-zone Mahogany)
KR102648506B1 (en) Cosmetic composition containing mangrove root and guaajava leaf
KR102447044B1 (en) Cosmetic composition for anti-oxidation or whitening
JP3150841B2 (en) External preparation for skin
JP2003335623A (en) Skin care preparation for external use